According to The Insight Partners market research study titled 'Cancer Tissue Diagnostics Market to 2027 – Global Analysis and Forecasts by Test Type'. The Global Cancer Tissue Diagnostics Market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 Mn in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027. The report highlights the trends prevalent in the global cancer tissue diagnostics market and the factors driving the market along with those that act as deterrents to its growth.
The global cancer tissue diagnostics market is expected to reach US$ 3,419.61 Mn in 2027 from US$ 2,025.41 in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.
Global Tissue Diagnostics Market is expected to rise from its initial estimated value of USD 3.94 billion in 2018 to an estimated value of USD 6.87 billion by 2026, registering a CAGR of 7.2% in the forecast period of 2019-2026. This market value can be attributed to the increasing number of cancer cases which is one of the major applications of tissue diagnostics.
Big Market Research provides a new Report Package "Global Cancer Biomarkers Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Info At: http://www.bigmarketresearch.com/global-cancer-biomarkers-2015-2019-market Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs. Get Enquire About This Report At: http://www.bigmarketresearch.com/report-enquiry/169860
According to the latest research report by IMARC Group, The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028. More Info:- https://www.imarcgroup.com/cancer-biomarkers-market
The global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. See Full Report : http://bit.ly/1GfXr2c
The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include: New accreditation requirements that have increased the cost structure of cord blood banks A decline in cord blood transplants in 2013, within the U.S. and other geographical regions Low rates of turnover for stored cord blood units See Full Report @ bit.ly/148Efow
The North American Laboratory Information systems market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. U.S. hold larger share in the laboratory information systems market, Canadian region is expected to grow at the highest CAGR of 8.3% in the forecast period. Browse full report @ http://bit.ly/1cvqzYr
The North American Laboratory Information systems market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. U.S. hold larger share in the laboratory information systems market, Canadian region is expected to grow at the highest CAGR of 8.3% in the forecast period. Browse full report @ http://bit.ly/1cvqzYr
According to the latest research report by IMARC Group, The global oncology molecular diagnostics market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.9% during 2023-2028. More Info:- https://www.imarcgroup.com/oncology-molecular-diagnostics-market
The growing number of clinical trials and the increasing adoption of immunoassay techniques are among the primary factors driving the cancer/tumor profiling market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cancer-tumor-profiling-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Looking forward, the oncology molecular diagnostics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/oncology-molecular-diagnostics-market
Loop-mediated Isothermal Amplification (LAMP) Market: Increasing Demand for Point-of-Care Systems for Nucleic Acid Identification to Elevate the Number of Use Cases: Global Industry Analysis (2013-2017) & Opportunity Assessment (2018-2028)
According to #TechSci Research report, India Minimally Invasive Surgical Devices Market stood at USD641.60 million in FY2021 and is expected to grow at a steady CAGR of 5.94% by 2027. Gain More Insight: https://bit.ly/3GAIISn Get Sample Report: https://bit.ly/3rBSz67 Press Release: https://bit.ly/34LcPcp Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
Global Molecular Diagnostics Market is anticipated to cross USD 22 Billion by the end of year 2025. Global Forecast by Application, Technology, End User, Regions, Companies. Call Us : +1 678-302-0700 Follow the Link for More Information: https://www.renub.com/molecular-diagnostics-market-nd.php
Access Complete Report at - https://www.theinsightpartners.com/reports/perfusion-systems-market Perfusion Systems Market is expected to witness massive growth during the forecast period from 2019-2027, due to Significant Growth of Pharmaceutical and Biotechnology Industries. The Asia Pacific perfusion systems market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on perfusion systems. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.
Global immunofluorescence market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the various innovations and advancements being presented by the different market players in terms of products related to this technology.
Immunofluorescence technique is based on the primary biological samples and is generally defined as the technique of utilizing light microscopy in combination with fluorescence microscope on various microbiological samples. The various microbiological samples involve study of tissues and cells. This study is ideal for clinical research on various diseases, such as therapeutics development and diagnosis.
Global human microbiome market is expected to rise by 2026, registering a healthy CAGR of 28.2% in the forecast period of 2019-2026. This rise in the market can be attributed to the rise in the advanced technology, increase in the aging population and rise in incidence of chronic diseases.
Future Market Insights (FMI), in its latest publication, outlines the future trajectory of the global nucleic acid isolation and purification market through 2029. According to the report, worldwide sales of nucleic acid isolation and purification kits were valued at ~US$ 830 million in 2018, and are estimated to register a Y-o-Y growth of ~4% in 2019.
Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers
The X-ray imaging systems category dominated the global market and generated revenue worth $15.2 billion in 2018, which is projected to reach $20.5 billion by 2024, progressing at a CAGR of 5.2% during the forecast period (2019–2024). Besides, the industry witnessed fastest growth in the category of nuclear imaging systems. The growth of this category is mainly driven by increasing prevalence of cancer, and rising demand for these systems across the globe. Furthermore, the market size for ultrasound systems, which stood at $5.9 billion in 2018, is expected to reach $8.3 billion by 2024, witnessing a CAGR of 6.0% during the forecast period.
The expanding healthcare industry and the elevating focus on patient safety are among the primary factors driving the whole imaging market. In addition to this, the rising prevalence of cancer, owing to the changing lifestyles, escalating smoking habits of consumers, genetic mutation, etc Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/whole--imaging-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Muscle Stimulation Devices Market: Adoption of Combination Devices to Gain Visible Traction in Developing Economies: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
The global near infrared imaging market size reached USD 950.1 Million in 2021, and is expected to register a CAGR of 10.1% during the forecast period, according to latest analysis by Emergen Research. Near infrared imaging is a diagnostic tool used for tissue imaging as it is minimally invasive and non-ionizing. It mainly uses near-infrared radiations within a range of 780 nm to 2500 nm. This technique is used to check the concentration and oxygenation of hemoglobin in the brain, muscles, and other tissues. It provides better imaging clarity than conventional methods. This technique is also widely used in applications, such as cardiovascular surgeries, cancer surgeries, plastic surgeries, and preclinical imaging.
The growing number of clinical trials and the increasing adoption of immunoassay techniques are among the primary factors driving the cancer/tumor profiling market. Moreover, the launch of various favorable policies by government bodies across countries for introducing numerous innovative techniques to reduce the time taken for the detection and identification of tumors is further catalyzing the market growth For an Executive Summary of Finance Cloud Report Visit the following link: https://www.imarcgroup.com/cancer-tumor-profiling-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The escalating prevalence of various cancers, such as leukemia and lymphoma, owing to the stressful lives, longer working hours, and excessive smoking and alcohol consumption is among the primary factors driving the cord blood banking services market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cord-blood-banking-services-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
According to Renub Research, Europe Biopsy Devices Market will reach US$ 996.3 Million in 2027. A biopsy is a medical operation that removes tissues or cells from the organs to aid in examining disorders. Surgeons, radiologists, cardiologists, and other medical professionals undertake the procedure using biopsy devices. These devices are made to remove diagnostic-quality specimens while minimizing crush artifacts and tissue fragmentation. Biopsy guiding systems, needle-based biopsy guns, biopsy needles, and biopsy forceps are the most often used biopsy instruments.
The global aspiration & biopsy needles market size was USD 875.3 Million in 2021 and is expected to register a revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer cases owing to various lifestyle changes, rapid urbanization and rising pollution levels, and changing consumption habits and increasing cancer awareness programs and screening and tests by governments and various global health organizations are some of the key factors driving global aspiration and biopsy needles market revenue growth. According to World Cancer Research Fund International, around 18,094,716 million cases of cancer were diagnosed in 2020.
According to the latest research report by IMARC Group, The global nuclear medicine equipment market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.65% during 2023-2028. More Info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market
Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026
Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026, registering a CAGR of 6.35% in the forecast period of 2019-2026.
According to the latest research report by IMARC Group, The global cell isolation market size reached US$ 11.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.7% during 2023-2028. More Info:- https://www.imarcgroup.com/cell-isolation-market
Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026
Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026
According to the latest research report by IMARC Group, The global positron emission tomography market size reached US$ 1,084 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,512 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028. More Info:- https://www.imarcgroup.com/positron-emission-tomography-market
According to the latest research report by IMARC Group, The global array instruments market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028. More Info:- https://www.imarcgroup.com/array-instruments-market
It highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities and investments. The in-depth analysis of facility management market report will help the clients to assess their business strategies as per the competitive environment in the market space.
The global organic electronics market size is expected to reach USD 178.25 Billion at a steady CAGR of 15.4% in 2028, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to rising demand for consumer electronic products and increasing focus on integrating advanced functionalities at reduced cost. Organic electronics offer several more benefits as compared to electronic products based on inorganic materials such as silicon and gallium arsenide.
Global immunofluorescence market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the various innovations and advancements being presented by the different market players in terms of products related to this technology.
The global liquid fertilizer market is estimated to reach value of USD 3.07 Billion by 2027, according to a current analysis by Emergen Research. In farming, fertilizers is one of the largest expenses and hence, determining the suitable fertilizer and its correct application process is crucial. One of the greatest advantages of using liquid fertilizers is their immediate penetration. Also they helps the plant get easy access to nutrients. Several farmers use liquid fertilizers to obtain immediate root growth in early season.
The global medical device contract manufacturing market is anticipated to grow at a double digit CAGR during the forecast period. Medical device contract manufacturing organization provide services to outsource manufacturing of devices that enables original equipment manufacturers (OEMs) to reduce cost of product, product packaging and transport of product.
The global Artificial Intelligence Market is expected to reach USD 348.99 Billion by 2027, according to a new report by Emergen Research. The increasing need for understanding consumer needs and market trends is one of the major factors driving the market growth. Moreover, the extensive adoption of smartphones, along with the popularity of social media, will also boost the growth of the market in the coming years.
Tackling these challenges and contributing significantly to the process of improving healthcare, we have shortlisted some of the prominent companies that are dedicatedly working to better the quality of life for people. In our issue, “Best of 10 Healthcare Brands 2019”, we highlight their stories and how they are catering this vast industry.
The ability of advanced technologies in solving a wide range of issues for patients, hospitals, and the healthcare industry is the impulse behind its sudden rising implementation in healthcare.With this regard, we have come up with ‘Best Healthcare Startups to Watch for 2019’ issue in which we have introduced the leading organizations that are spearheading the healthcare field with their innovative services and solutions.
Looking forward, the array instruments market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/array-instruments-market
Looking forward, the biopsy devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/biopsy-devices-market
Looking forward, the positron emission tomography market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/positron-emission-tomography-market